Publication:
Towards uncovering the role of incomplete penetrance in maculopathies through sequencing of 105 disease-associated genes

dc.contributor.coauthorHitti-Malin, Rebekkah J.
dc.contributor.coauthorPanneman, Daan M.
dc.contributor.coauthorCorradi, Zelia
dc.contributor.coauthorBoonen, Erica G. M.
dc.contributor.coauthorAstuti, Galuh
dc.contributor.coauthorDhaenens, Claire-Marie
dc.contributor.coauthorStoehr, Heidi
dc.contributor.coauthorWeber, Bernhard H. F.
dc.contributor.coauthorSharon, Dror
dc.contributor.coauthorBanin, Eyal
dc.contributor.coauthorKarali, Marianthi
dc.contributor.coauthorBanfi, Sandro
dc.contributor.coauthorBen-Yosef, Tamar
dc.contributor.coauthorGlavac, Damjan
dc.contributor.coauthorFarrar, G. Jane
dc.contributor.coauthorAyuso, Carmen
dc.contributor.coauthorLiskova, Petra
dc.contributor.coauthorDudakova, Lubica
dc.contributor.coauthorVajter, Marie
dc.contributor.coauthorOldak, Monika
dc.contributor.coauthorSzaflik, Jacek P.
dc.contributor.coauthorMatynia, Anna
dc.contributor.coauthorGorin, Michael B.
dc.contributor.coauthorKaempjaervi, Kati
dc.contributor.coauthorBauwens, Miriam
dc.contributor.coauthorDe Baere, Elfride
dc.contributor.coauthorHoyng, Carel B.
dc.contributor.coauthorLi, Catherina H. Z.
dc.contributor.coauthorKlaver, Caroline C. W.
dc.contributor.coauthorInglehearn, Chris F.
dc.contributor.coauthorFujinami, Kaoru
dc.contributor.coauthorRivolta, Carlo
dc.contributor.coauthorAllikmets, Rando
dc.contributor.coauthorZernant, Jana
dc.contributor.coauthorLee, Winston
dc.contributor.coauthorPodhajcer, Osvaldo L.
dc.contributor.coauthorFakin, Ana
dc.contributor.coauthorSajovic, Jana
dc.contributor.coauthorAltalbishi, Alaa
dc.contributor.coauthorValeina, Sandra
dc.contributor.coauthorTaurina, Gita
dc.contributor.coauthorVincent, Andrea L.
dc.contributor.coauthorRoberts, Lisa
dc.contributor.coauthorRamesar, Raj
dc.contributor.coauthorSartor, Giovanna
dc.contributor.coauthorLuppi, Elena
dc.contributor.coauthorDownes, Susan M.
dc.contributor.coauthorvan den Born, L. Ingeborgh
dc.contributor.coauthorMclaren, Terri L.
dc.contributor.coauthorDe Roach, John N.
dc.contributor.coauthorLamey, Tina M.
dc.contributor.coauthorThompson, Jennifer A.
dc.contributor.coauthorChen, Fred K.
dc.contributor.coauthorTracewska, Anna M.
dc.contributor.coauthorKamakari, Smaragda
dc.contributor.coauthorSallum, Juliana Maria Ferraz
dc.contributor.coauthorBolz, Hanno J.
dc.contributor.coauthorRoosing, Susanne
dc.contributor.coauthorCremers, Frans P. M.
dc.contributor.kuauthorKayserili, Hülya
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.date.accessioned2024-12-29T09:36:38Z
dc.date.issued2024
dc.description.abstractInherited macular dystrophies (iMDs) are a group of genetic disorders, which affect the central region of the retina. To investigate the genetic basis of iMDs, we used single-molecule Molecular Inversion Probes to sequence 105 maculopathy-associated genes in 1352 patients diagnosed with iMDs. Within this cohort, 39.8% of patients were considered genetically explained by 460 different variants in 49 distinct genes of which 73 were novel variants, with some affecting splicing. The top five most frequent causative genes were ABCA4 (37.2%), PRPH2 (6.7%), CDHR1 (6.1%), PROM1 (4.3%) and RP1L1 (3.1%). Interestingly, variants with incomplete penetrance were revealed in almost one-third of patients considered solved (28.1%), and therefore, a proportion of patients may not be explained solely by the variants reported. This includes eight previously reported variants with incomplete penetrance in addition to CDHR1:c.783G>A and CNGB3:c.1208G>A. Notably, segregation analysis was not routinely performed for variant phasing-a limitation, which may also impact the overall diagnostic yield. The relatively high proportion of probands without any putative causal variant (60.2%) highlights the need to explore variants with incomplete penetrance, the potential modifiers of disease and the genetic overlap between iMDs and age-related macular degeneration. Our results provide valuable insights into the genetic landscape of iMDs and warrant future exploration to determine the involvement of other maculopathy genes.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue3
dc.description.openaccessgold
dc.description.publisherscopeInternational
dc.description.sponsorsThis research was funded by the HRCI HRB Joint Funding Scheme 2020-007, Stichting Oog fonds Nederland (UZ 2020-17), Pro Retina Deutschland, Stichting tot Verbetering van het Lot derBlinden, Stichting voor Ooglijders and Stichting Blindenhulp (R.J.H.M, S.R, F.P.M.C). The following funding resources also, in part, supported this work: GA UK n.321522 (to P.L. and M.V.) and AZV NU20-07-00182 research grant from the Ministry of Health of the Czech Republic (to P.L. and L.D.);Retina Australia (J.N.D., J.A.T., T.L.M., T.M.L.), Australian National Health and Medical Research Council (MRF1142962, F.K.C.); WA Health (F.K.C.); Retina South Africa and the South African Medical Research Council (MRC) and Velux Stiftung (L.R., R.R.); the National Science Center (Poland) grant number N N402 591640 (5916/B/P01/2011/40) (M.O.); RP Fighting Blindness and Fight for Sight UK (RP Genome Project GR586) (C.F.I.); NIH/NEI grants R01EY028203, R01EY028954, R01EY029315,P30EY019007, Foundation Fighting Blindness award PPA-1218-0751-COLU, and the Unrestricted funds from the Research to Prevent Blindness (RPB) to the Department of Ophthalmology, Columbia University, New York, NY, USA. (R.A., W.L. and J.Z.).
dc.description.volume14
dc.identifier.doi10.3390/biom14030367
dc.identifier.eissn2218-273X
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85188807245
dc.identifier.urihttps://doi.org/10.3390/biom14030367
dc.identifier.urihttps://hdl.handle.net/20.500.14288/22097
dc.identifier.wos1191236500001
dc.keywordsMaculopathies
dc.keywordsMacula
dc.keywordsRetinal
dc.keywordsInherited
dc.keywordsSequencing
dc.keywordsPenetrance
dc.languageen
dc.publisherMDPI
dc.relation.grantnoHRCI HRB Joint Funding Scheme [2020-007]
dc.relation.grantnoStichting Oog fonds Nederland
dc.relation.grantnoGA UK [321522, AZV NU20-07-00182]
dc.relation.grantnoMinistry of Health of the Czech Republic
dc.relation.grantnoRetina Australia
dc.relation.grantnoAustralian National Health and Medical Research Council [MRF1142962]
dc.relation.grantnoWA Health
dc.relation.grantnoRetina South Africa and the South African Medical Research Council (MRC) and Velux Stiftung
dc.relation.grantnoNational Science Center (Poland) [N N402 591640, 5916/B/P01/2011/40]
dc.relation.grantnoRP Fighting Blindness and Fight for Sight UK [GR586]
dc.relation.grantnoNIH/NEI [R01EY028203, R01EY028954, R01EY029315, P30EY019007]
dc.relation.grantnoFoundation Fighting Blindness [PPA-1218-0751-COLU]
dc.relation.grantnoUnrestricted funds from the Research to Prevent Blindness (RPB) to the Department of Ophthalmology, Columbia University, New York, NY, USA
dc.sourceBiomolecules
dc.subjectBiochemistry and molecular biology
dc.titleTowards uncovering the role of incomplete penetrance in maculopathies through sequencing of 105 disease-associated genes
dc.typeJournal article
dspace.entity.typePublication
local.contributor.kuauthorKayserili, Hülya

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
IR05059.pdf
Size:
1.27 MB
Format:
Adobe Portable Document Format